UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 136

Sortiert nach

234: MMP2 as a molecular biomarker of proficient tumor–stroma cross-talk in lung cancer

European journal of cancer (1990), 2014-07, Vol.50, p.S54-S54

2014

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of arterial hypertension after the constriction of the renal artery leaving the opposite kidney intact both in the anaesthetized and in the conscious dog

Clinical science (1933), 1972-06, Vol.42 (6), p.651

1972

Link zum Volltext

Verfügbarkeit prüfen

Prolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors

Il Farmaco; edizione scientifica, 1988-12, Vol.43 (12), p.989

1988

Link zum Volltext

Verfügbarkeit prüfen

Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. I. Studies in the rat

Xenobiotica, 1985, Vol.15 (12), p.1069-1087

1985

Link zum Volltext

Verfügbarkeit prüfen

Initial data on the protective effect of thioctic acid in x-irradiation

Bollettino della Societa italiana di biologia sperimentale, 1957-04, Vol.33 (4), p.408

1957

Link zum Volltext

Verfügbarkeit prüfen

Mechanism of action of a new hypotensive agent: 3-hydrazino-6-(N,N-bis-(2-hydroxyethyl)-amino)-pyridazine chlorhydrate (L 6150)

Bollettino chimico farmaceutico, 1972-08, Vol.111 (8), p.480

1972

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms involved in renal hypertension

Kidney international. Supplement, 1975-09, p.S165

1975

Link zum Volltext

Verfügbarkeit prüfen

Selection of two strains of rats with inherited hypertension. Preliminary studies with some hypotensive drugs

British journal of pharmacology, 1968-11, Vol.34 (3), p.680P-681P

1968

Link zum Volltext

Verfügbarkeit prüfen

Beta adrenergic receptors in the coronary vessels

Bollettino della Societa italiana di cardiologia, 1980, Vol.25 (8), p.949

1980

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of hydrazine pyridazine with hypotensive activity. II

Il Farmaco; edizione scientifica, 1972-07, Vol.27 (7), p.591

1972

Link zum Volltext

Verfügbarkeit prüfen

ACTION OF 2-(3,3-DIPHENYLPROPYLAMINO)-3-METHYLAMINO-N-PHENYLBUTYLAMINE PHOSPHATE (DF-154) ON THE EXTRAHEPATIC BILE DUCTS

Archivio italiano di scienze farmacologiche, 1963-01, Vol.13, p.43

1963

Link zum Volltext

Verfügbarkeit prüfen

Substances with potential cardiovascular action. 2-acylaminobenzimidazoles with hypotensive activity

Il Farmaco; edizione scientifica, 1973-02, Vol.28 (2), p.164

1973

Link zum Volltext

Verfügbarkeit prüfen

Highly selective antiinflammatory and analgesic activity of 3-(1-methylethyl)-2-(4-methoxyphenyl)-3H-naphth[1,2-d]imidazole, a new non-acidic molecule

Arzneimittel-Forschung, 1986, Vol.36 (1), p.102

1986

Link zum Volltext

Verfügbarkeit prüfen

Synthesis, in vitro [3H]prazosin displacement, and in vivo activity of 3-aryl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines, a new class of antihypertensive agents

Journal of medicinal chemistry, 1985-07, Vol.28 (7), p.934-940

1985

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator

Arzneimittel-Forschung, 1985, Vol.35 (5), p.818

1985

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs

Arzneimittel-Forschung, 1986, Vol.36 (1), p.84

1986

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic profile of a new cerebral vasodilator, vincamine and of one of its derivatives, apovincaminic acid ethylester (RGH-4405)

Archives internationales de pharmacodynamie et de thérapie, 1977-03, Vol.226 (1), p.139

1977

Link zum Volltext

Verfügbarkeit prüfen

Antihypertensives. N-1H-Pyrrol-1-yl-3-pyridazinamines

Journal of medicinal chemistry, 1984-08, Vol.27 (8), p.1077-1083

1984

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl)carbonyl]-L-prolines

Journal of medicinal chemistry, 1986-03, Vol.29 (3), p.411-417

1986

Link zum Volltext

Verfügbarkeit prüfen

Anti-hypertensives: 1-alkyl-2-arylpiperazinoethyl-1H-naphth[1,2-d]imidazoles

European journal of medicinal chemistry, 1987-05, Vol.22 (3), p.221-228

1987

Link zum Volltext

Verfügbarkeit prüfen

Imidazolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors

Il Farmaco; edizione scientifica, 1985-08, Vol.40 (8), p.541

1985

Link zum Volltext

Verfügbarkeit prüfen

Angiotension converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl) carbonyl]-L-prolines

Journal of medicinal chemistry, 1986, Vol.29 (3), p.411-417

1986

Link zum Volltext

Verfügbarkeit prüfen

Activity of β2 adrenergic receptors in coronary arteries after cardioselective β-blockade

Basic research in cardiology, 1981-09, Vol.76 (5), p.540-544

1981

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic activity of L 6150. Systemic and coronary circulation

Naunyn-Schmiedeberg's archives of pharmacology, 1973, Vol.279 (3), p.301-312

1973

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic activity of L6150: Systemic and coronary circulation

Naunyn-Schmiedeberg's archives of pharmacology, 1973-01, Vol.279 (3), p.301-312

1973

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

234: MMP2 as a molecular biomarker of proficient tumor–stroma cross-talk in lung cancer

Pathogenesis of arterial hypertension after the constriction of the renal artery leaving the opposite kidney intact both in the anaesthetized and in the conscious dog

Prolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors

Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. I. Studies in the rat

Initial data on the protective effect of thioctic acid in x-irradiation

Mechanism of action of a new hypotensive agent: 3-hydrazino-6-(N,N-bis-(2-hydroxyethyl)-amino)-pyridazine chlorhydrate (L 6150)

Mechanisms involved in renal hypertension

Selection of two strains of rats with inherited hypertension. Preliminary studies with some hypotensive drugs

Beta adrenergic receptors in the coronary vessels

Synthesis of hydrazine pyridazine with hypotensive activity. II

ACTION OF 2-(3,3-DIPHENYLPROPYLAMINO)-3-METHYLAMINO-N-PHENYLBUTYLAMINE PHOSPHATE (DF-154) ON THE EXTRAHEPATIC BILE DUCTS

Substances with potential cardiovascular action. 2-acylaminobenzimidazoles with hypotensive activity

Highly selective antiinflammatory and analgesic activity of 3-(1-methylethyl)-2-(4-methoxyphenyl)-3H-naphth[1,2-d]imidazole, a new non-acidic molecule

Synthesis, in vitro [3H]prazosin displacement, and in vivo activity of 3-aryl-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridines, a new class of antihypertensive agents

Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator

Hemodynamic profile of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride in conscious dogs

Hemodynamic profile of a new cerebral vasodilator, vincamine and of one of its derivatives, apovincaminic acid ethylester (RGH-4405)

Antihypertensives. N-1H-Pyrrol-1-yl-3-pyridazinamines

Angiotensin converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl)carbonyl]-L-prolines

Anti-hypertensives: 1-alkyl-2-arylpiperazinoethyl-1H-naphth[1,2-d]imidazoles

Imidazolyl derivatives of enalapril as potential angiotensin converting enzyme inhibitors

Angiotension converting enzyme inhibitors as antihypertensive agents: 1-[(2-mercaptocycloalkyl) carbonyl]-L-prolines

Activity of β2 adrenergic receptors in coronary arteries after cardioselective β-blockade

Hemodynamic activity of L 6150. Systemic and coronary circulation

Hemodynamic activity of L6150: Systemic and coronary circulation

Suchergebnisse filtern